Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

BNOX
Bionomics Limited
stock NASDAQ

Inactive
Dec 23, 2024
0.2531USD+4.199%(+0.0102)7,434,476
Pre-market
0.00USD-100.000%(-0.24)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 14, 2022
07:09AM EST  Bionomics To Ring Nasdaq Stock Market Closing Bell On Jan. 14   RTTNews
07:07AM EST  Bionomics Limited (Nasdaq: BNOX, ASX: BNO) to Ring the Nasdaq Stock Market   PR Newswire
Jan 12, 2022
06:00AM EST  Bionomics Limited participated in the H.C Wainwright BioConnect Conference   PR Newswire
Jan 10, 2022
10:47AM EST  Cantor Fitzgerald Initiates Coverage On Bionomics with Overweight Rating, Announces Price Target of $52   Benzinga
10:06AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2022   Benzinga
07:41AM EST  The Week Ahead In Biotech (Jan 10-15): JPMorgan Healthcare Conference Front And Center, Preannouncements Keep Coming   Benzinga
07:24AM EST  Evercore ISI Group Initiates Coverage On Bionomics with Outperform Rating, Announces Price Target of $17   Benzinga
06:55AM EST  Berenberg Initiates Coverage On Bionomics with Buy Rating, Announces Price Target of $21   Benzinga
Jan 5, 2022
05:59PM EST  Bionomics Limited Announces Full Exercise of Underwriters' Option to Purchase   PR Newswire
Jan 4, 2022
10:58AM EST  Stocks That Breached 52-Week Lows Today   Benzinga
Jan 3, 2022
06:06AM EST  Bionomics Initiates Phase 2 PREVAIL Study Of BNC210 For The Acute Treatment Of Social Anxiety Disorder   Benzinga
06:02AM EST  Bionomics Initiates Phase 2 PREVAIL Study Of BNC210 For Acute Treatment Of Social Anxiety Disorder   RTTNews
06:00AM EST  Bionomics Initiates Phase 2 PREVAIL Study of BNC210 for the Acute Treatment of   PR Newswire
Dec 19, 2021
12:54PM EST  The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week   Benzinga
Dec 16, 2021
11:51AM EST  Bionomics Limited Shares Opened For Trade At $22; IPO Priced $12.35/ADS   Benzinga
09:28AM EST  Bionomics Limited Shares Will Open For Quote At 10:35 a.m. EST, Expected To Open For Trade After 10:45 a.m. EST; IPO Priced $12.35/ADS   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC